BioSpace News Archive

Medline and Spectramed announced an exclusive collaboration to optimize patient outcomes around the treatment of dysphagia, the difficulty of swallowing, and related muscle weakness.

Somatus has been awarded access to the Centers for Medicare & Medicaid Services’ Virtual Research Data Center through the 2019 Health Equity Data Access Program for Cohort 2 and will be partnering with Johns Hopkins Center for Health Equity to co-lead the study.

Two teams of scientists from the Wake Forest Institute for Regenerative Medicine in Winston-Salem, North Carolina, have won first and second place in NASA’s Vascular Tissue Challenge.

nanoMesh™ LLC, a subsidiary of Exogenesis Corporation, announced today that it has successfully achieved the secondary endpoints for the nanoMesh™ Pathogen Inhibiting Protein (PIP) uptake studies.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that Dave Bailey, Chief Executive Officer, Fred Hite, Chief Operating Officer and Chief Financial Officer, and Mark Throdahl, Executive Chairman, are scheduled to participate in the 2021 JMP Securities Life Sciences Conference on Thursday, June 17, 2021.

Zynerba Pharmaceuticals, Inc., the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, announced that it has adjourned its 2021 Annual Meeting of Stockholders due to a lack of quorum.

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Sue-Jean Lin has been appointed to the Arcutis Board of Directors

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that Ryan Spencer, Chief Executive Officer, will present virtually at the Goldman Sachs 42nd Annual Global Healthcare Conference.

OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), today announced that the Company conducted its 2021 annual stockholders meeting (the “Annual Meeting”) and adjourned the meeting solely with respect to Proposal 2 set forth in its Definitive Proxy Statement (the “Proxy Statement”) filed with the Securities and Exchange Commission on April 26, 2021.

Omeros Corporation (Nasdaq: OMER), today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the BofA 2021 Napa BioPharma Virtual Conference next week.